ReachMD
Be part of the knowledge.™Public Profile
Amit Singal, MD, MS
- David Bruton Jr. Prof, Clinical Cancer Research
- Professor, Medicine
- Chief and Medical Director, Liver Tumor Program
- UT Southwestern Medical Center
Amit Singal, MD, MS, is a professor of medicine and chief of Hepatology at UT Southwestern Medical Center in Dallas, TX. He is an expert in hepatocellular carcinoma and serves as the Medical Director of the UT Southwestern Liver Tumor Program. Dr Singal received his medical degree from the University of Michigan Medical School in Ann Arbor, MI. He completed his residency in internal medicine at the University of Washington School of Medicine in Seattle, WA. He then completed fellowships in gastroenterology and transplant hepatology at the University of Michigan Medical Center. Dr Singal is board certified in gastroenterology and transplant hepatology.
Dr Singal’s research focuses on diagnosing and treating liver cancer before it becomes incurable. He has received numerous grants, including from the National Institutes of Health (NIH), Cancer Prevention Research Institute of Texas (CPRIT), and the Department of Defense, and he lectures on his work frequently throughout the world.
Dr Singal is a member of multiple professional organizations, including the American Gastroenterological Association, the American College of Gastroenterology, and the American Association for the Study of Liver Diseases, and he serves on the International Liver Cancer Association’s Executive Committee. He is also on the editorial board for several journals, including serving as Associate Editor for Clinical Gastroenterology and Hepatology.
Dr Singal has published over 200 scientific papers regarding HCC screening and treatment. For his work, he has been awarded the David Bruton Professorship in Clinical Cancer Research and Blue Faery Award for Excellence in Liver Cancer Research.
Dr Singal’s research focuses on diagnosing and treating liver cancer before it becomes incurable. He has received numerous grants, including from the National Institutes of Health (NIH), Cancer Prevention Research Institute of Texas (CPRIT), and the Department of Defense, and he lectures on his work frequently throughout the world.
Dr Singal is a member of multiple professional organizations, including the American Gastroenterological Association, the American College of Gastroenterology, and the American Association for the Study of Liver Diseases, and he serves on the International Liver Cancer Association’s Executive Committee. He is also on the editorial board for several journals, including serving as Associate Editor for Clinical Gastroenterology and Hepatology.
Dr Singal has published over 200 scientific papers regarding HCC screening and treatment. For his work, he has been awarded the David Bruton Professorship in Clinical Cancer Research and Blue Faery Award for Excellence in Liver Cancer Research.